91 related articles for article (PubMed ID: 23563700)
1. Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.
Ren M; Hong M; Liu G; Wang H; Patel V; Biddinger P; Silva J; Cowell J; Hao Z
Oncol Rep; 2013 Jun; 29(6):2181-90. PubMed ID: 23563700
[TBL] [Abstract][Full Text] [Related]
2. Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC.
Singleton KR; Hinz TK; Kleczko EK; Marek LA; Kwak J; Harp T; Kim J; Tan AC; Heasley LE
Cancer Res; 2015 Oct; 75(20):4398-406. PubMed ID: 26359452
[TBL] [Abstract][Full Text] [Related]
3. FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.
Bogatyrova O; Mattsson JSM; Ross EM; Sanderson MP; Backman M; Botling J; Brunnström H; Kurppa P; La Fleur L; Strell C; Wilm C; Zimmermann A; Esdar C; Micke P
Eur J Cancer; 2021 Jul; 151():136-149. PubMed ID: 33984662
[TBL] [Abstract][Full Text] [Related]
4. Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.
Vlacic G; Hoda MA; Klikovits T; Sinn K; Gschwandtner E; Mohorcic K; Schelch K; Pirker C; Peter-Vörösmarty B; Brankovic J; Dome B; Laszlo V; Cufer T; Rozman A; Klepetko W; Grasl-Kraupp B; Hegedus B; Berger W; Kern I; Grusch M
Cells; 2019 Sep; 8(9):. PubMed ID: 31527449
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MicroRNA-214 Alleviates Lung Injury and Inflammation via Increasing FGFR1 Expression in Ventilator-Induced Lung Injury.
He K; Han S; An L; Zhang J
Lung; 2021 Feb; 199(1):63-72. PubMed ID: 33389067
[TBL] [Abstract][Full Text] [Related]
6. Genomic insights into the mechanisms of FGFR1 dependency in squamous cell lung cancer.
Mäkinen N; Meyerson M
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37909331
[TBL] [Abstract][Full Text] [Related]
7. Targeting FGFR1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models.
Zhao R; Yin F; Fredimoses M; Zhao J; Fu X; Xu B; Liang M; Chen H; Liu K; Lei M; Laster KV; Li Z; Kundu JK; Dong Z; Lee MH
Phytomedicine; 2024 Jul; 129():155612. PubMed ID: 38669968
[TBL] [Abstract][Full Text] [Related]
8. Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.
Malchers F; Nogova L; van Attekum MH; Maas L; Brägelmann J; Bartenhagen C; Girard L; Bosco G; Dahmen I; Michels S; Weeden CE; Scheel AH; Meder L; Golfmann K; Schuldt P; Siemanowski J; Rehker J; Merkelbach-Bruse S; Menon R; Gautschi O; Heuckmann JM; Brambilla E; Asselin-Labat ML; Persigehl T; Minna JD; Walczak H; Ullrich RT; Fischer M; Reinhardt HC; Wolf J; Büttner R; Peifer M; George J; Thomas RK
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37606995
[TBL] [Abstract][Full Text] [Related]
9. Expression and Purification of FGFR1-Fc Fusion Protein and Its Effects on Human Lung Squamous Carcinoma.
Zheng L; Liu H; Chen L; You X; Lv F; Fan H; Hui Q; Liu B; Wang X
Appl Biochem Biotechnol; 2024 Jan; 196(1):573-587. PubMed ID: 37160564
[TBL] [Abstract][Full Text] [Related]
10. The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells.
Poźniak M; Porębska N; Krzyścik MA; Sokołowska-Wędzina A; Jastrzębski K; Sochacka M; Szymczyk J; Zakrzewska M; Otlewski J; Opaliński Ł
Mol Med; 2021 May; 27(1):46. PubMed ID: 33962559
[TBL] [Abstract][Full Text] [Related]
11. The D647N mutation of FGFR1 induces ligand-independent receptor activation.
Domenichini M; Ravelli C; Corsini M; Codenotti S; Moreschi E; Gogna A; Capoferri D; Zizioli D; Bresciani R; Grillo E; Mitola S
Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130470. PubMed ID: 37778450
[TBL] [Abstract][Full Text] [Related]
12. Modular self-assembly system for development of oligomeric, highly internalizing and potent cytotoxic conjugates targeting fibroblast growth factor receptors.
Poźniak M; Porębska N; Jastrzębski K; Krzyścik MA; Kucińska M; Zarzycka W; Barbach A; Zakrzewska M; Otlewski J; Miączyńska M; Opaliński Ł
J Biomed Sci; 2021 Oct; 28(1):69. PubMed ID: 34635096
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of novel pyrimidinylaminothiophene derivatives as FGFR1 inhibitors against human glioblastoma multiforme.
Li YL; Yan LJ; Chen HX; Ruan BK; Dao P; Du ZY; Dong CZ; Meunier B
Eur J Med Chem; 2023 Nov; 260():115764. PubMed ID: 37651879
[TBL] [Abstract][Full Text] [Related]
14. FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies.
Weeden CE; Solomon B; Asselin-Labat ML
Cell Death Discov; 2015; 1():15049. PubMed ID: 27551478
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland.
Doddapaneni R; Tao W; Naranjo A; Nikpoor N; Tse DT; Pelaez D
Oncotarget; 2019 Jan; 10(4):480-493. PubMed ID: 30728899
[TBL] [Abstract][Full Text] [Related]
16. Oncogene alterations in non-small cell lung cancer with
Kitai H; Ebi H
Transl Lung Cancer Res; 2024 Mar; 13(3):684-688. PubMed ID: 38601453
[No Abstract] [Full Text] [Related]
17. In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692.
Dömötör O; Mathuber M; Kowol CR
Eur J Pharm Sci; 2024 Jan; 192():106651. PubMed ID: 38013124
[TBL] [Abstract][Full Text] [Related]
18. Ponatinib-Induced Cardiomyocyte Toxicity: Dark Side of the Integrated Stress Response.
Liang FG; Moslehi J; Kitsis RN
Circ Res; 2024 Mar; 134(5):502-504. PubMed ID: 38422183
[No Abstract] [Full Text] [Related]
19. From the eosinophil to a novel FGFR1 fusion gene.
Harper K; Horne G; Leach M; Bain BJ
Am J Hematol; 2024 Feb; ():. PubMed ID: 38400516
[No Abstract] [Full Text] [Related]
20. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH
Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
